See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Comtech Telecommunications Corp. (CMTL) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Comtech Telecommunications Corp. (CMTL) - free report >>
Image: Bigstock
New Strong Sell Stocks for June 25th
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Calavo Growers, Inc. (CVGW - Free Report) is a global avocado-industry leader and an expanding provider of value-added fresh food. The Zacks Consensus Estimate for its current year earnings has been revised nearly 16% downward over the last 30 days.
Chinook Therapeutics, Inc. is a clinical-stage biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 1.9% downward over the last 30 days.
Comtech Telecommunications Corp. (CMTL - Free Report) designs, develops, produces and markets innovative products, systems and services for advanced communications solutions. The Zacks Consensus Estimate for its current year earnings has been revised 3.4% downward over the last 30 days.
Great Panther Mining Limited is engaged in the production of silver. The Zacks Consensus Estimate for its current year earnings has been revised 11.1% downward over the last 30 days.
Travere Therapeutics, Inc. (TVTX - Free Report) is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 0.6% downward over the last 30 days.
View the entire Zacks Rank #5 List.